RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

  • FDA Cites Military-tech Company for Marketing Medical Device Without Approval

    A company marketing several medical devices intended to be used in combat situations has been cited by the US Food and Drug Administration (FDA) for marketing one without having sought approval from the agency and manufacturing numerous others in violation of current good manufacturing practices. In a warning letter released 9 May, FDA said Virginia-based manufacturer H&H Associates does not have "an approved application for premarket approval in effect" pursuant to ...
  • After Afghanistan Massacre, US Military Looks At Adverse Events

    • 26 March 2012
    • By
    Top US Department of Defense (DoD) officials are ordering an emergency review of the adverse events surrounding the use of anti-malarial drug mefloquine after a US soldier allegedly massacred 17 Afghan civilians last week, reports The Huffington Post . The drug, also known as Lariam, is associated with a long list of side effects, including psychotic behavior, paranoia and hallucinations, reports The Post . A 2009 review of the drug by the DoD almost banned the drug ...